SUSTAINED EFFICACY AND LONG-TERM SAFETY OF ERENUMAB IN PATIENTS WITH EPISODIC MIGRAINE: RESULTS OF A 5-YEAR, OPEN-LABEL EXTENSION STUDY

被引:0
|
作者
Ashina, Messoud [1 ]
Goadsby, Peter J. [2 ,3 ]
Reuter, Uwe [4 ]
Silberstein, Stephen [5 ]
Dodick, David W. [6 ]
Xue, Fei [7 ]
Zhang, Feng [7 ]
Cheng, Sunfa [7 ]
Chou, Denise E. [7 ]
Lima, Gabriel Paiva da Silva [7 ]
机构
[1] Univ Copenhagen, Fac Hlth & Med Sci, Rigshosp Glostrup, Dept Neurol,Danish Headache Ctr, Copenhagen, Denmark
[2] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA
[3] Kings Coll London, NIHR Wellcome Trust Kings Clin Res Facil, London, England
[4] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany
[5] Thomas Jefferson Univ, Jefferson Headache Ctr, Philadelphia, PA 19107 USA
[6] Mayo Clin, Dept Neurol, Scottsdale, AZ USA
[7] Amgen Inc, Thousand Oaks, CA 91320 USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
MTV20-DP-0
引用
收藏
页码:60 / 61
页数:2
相关论文
共 50 条
  • [1] Sustained Efficacy and Long-term Safety of Erenumab in Patients with Episodic Migraine: 4+Year Results of a 5-Year, Open-Label Extension Study
    Ashina, M.
    Goadsby, P. J.
    Reuter, U.
    Silberstein, S. D.
    Dodick, D. W.
    Chou, D. E.
    Klatt, J.
    Xue, F.
    Zhang, F.
    Cheng, S.
    Mikol, D. D.
    [J]. HEADACHE, 2019, 59 : 25 - 25
  • [2] Sustained Efficacy and Long-term Safety of Erenumab in Patients with Episodic Migraine: 4+Year Results of a 5-year, Open-label Treatment Period
    Ashina, Messoud
    Goadsby, Peter
    Reuter, Uwe
    Silberstein, Stephen
    Dodick, David
    Xue, Fei
    Zhang, Feng
    Cheng, Sunfa
    Mikol, Daniel
    [J]. NEUROLOGY, 2020, 94 (15)
  • [3] Sustained efficacy and long-term safety of erenumab in patients with episodic migraine: 4+year results of a 5-year, open-label treatment period
    Ashina, Messoud
    Goadsby, Peter J.
    Reuter, Uwe
    Silberstein, Stephen
    Dodick, David W.
    Chou, Denise E.
    Pandhi, Shaloo
    Xue, Fei
    Zhang, Feng
    Cheng, Sunfa
    Mikol, Daniel D.
    [J]. CEPHALALGIA, 2019, 39 (1_SUPPL) : 365 - 366
  • [4] Consistent efficacy and safety of erenumab in episodic migraine patients during a 5-year, open-label extension study
    Ashina, M.
    Goadsby, P.
    Reuter, U.
    Silberstein, S.
    Dodick, D.
    Zhang, F.
    Xue, F.
    Cheng, S.
    Chou, D.
    Lima, G. Paiva da Silva
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 153 - 154
  • [5] Consistent efficacy and safety of erenumab over time in patients with episodic migraine who completed a 5-year, open-label extension study
    Ashina, M.
    Goadsby, P. J.
    Reuter, U.
    Silberstein, S. D.
    Dodick, D. W.
    Zhang, F.
    Xui, F.
    Cheng, S.
    Chou, D. E.
    Lima, G. Paiva Da Silva
    [J]. JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 17 - 17
  • [6] Consistent efficacy and safety of erenumab over time in patients with episodic migraine who completed a 5-year, open-label extension study
    Ashina, Messoud
    Goadsby, Peter
    Reuter, Uwe
    Silberstein, Stephen
    Dodick, David
    Zhang, Feng
    Xue, Fei
    Cheng, Sunfa
    Chou, Denise
    Lima, Gabriel Paiva da Silva
    [J]. NEUROLOGY, 2021, 96 (15)
  • [7] Consistent efficacy and safety of erenumab over time in patients with episodic migraine who completed a 5-year, open-label extension study
    Ashina, M.
    Goadsby, P. J.
    Reuter, U.
    Silberstein, S. D.
    Dodick, D. W.
    Zhang, F.
    Xui, F.
    Cheng, S.
    Chou, D. E.
    Lima, G. Paiva Da Silva
    [J]. CEPHALALGIA, 2021, 41 (1_SUPPL) : 25 - 26
  • [8] Consistent efficacy and safety of erenumab over time in patients with episodic migraine who completed a 5-year, open-label extension study
    Ashina, M.
    Goadsby, P. J.
    Reuter, U.
    Silberstein, S. D.
    Dodick, D. W.
    Zhang, F.
    Xue, F.
    Cheng, S.
    Chou, D. E.
    Lima, da Silva G. P.
    [J]. HEADACHE, 2021, 61 : 117 - 118
  • [9] Long-term efficacy and safety during open-label erenumab treatment in Japanese patients with episodic migraine
    Sakai, Fumihiko
    Takeshima, Takao
    Tatsuoka, Yoshihisa
    Hirata, Koichi
    Cheng, Sunfa
    Numachi, Yotaro
    Peng, Cheng
    Xue, Fei
    Mikol, Daniel D.
    [J]. HEADACHE, 2021, 61 (04): : 653 - 661
  • [10] Long-term safety and tolerability of erenumab: Three-plus year results from an ongoing open-label extension study in episodic migraine
    Ashina, Messoud
    Goadsby, Peter J.
    Reuter, Uwe
    Silberstein, Stephen
    Dodick, David
    Rippon, Gregory A.
    Klatt, Jan
    Zhang, Feng
    Cheng, Sunfa
    Mikol, Daniel D.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2018, 19